Clinical Trials
3 trialsNCT05265793 2022-03-04
Camrelizumab Combined With Apatinib in the Treatment of Advanced Sarcomatoid Carcinoma or Carcinosarcoma
Fudan University
Phase 2 Unknown
NCT03570437 2022-03-02
COPELIA
University of Manchester
Phase 2 Unknown
NCT05224999 2022-02-04
Nivolumab for Recurrent/Metastatic Carcinosarcoma
Yonsei University
Phase 2 Unknown